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We have investigated the bacterial-dependent metabolism of (2 )-epicatechin and (þ )-catechin using a pH-controlled, stirred, batch-culture
fermentation system reflective of the distal region of the human large intestine. Incubation of (2)-epicatechin or (þ )-catechin (150mg/l or
1000mg/l) with faecal bacteria, led to the generation of 5-(30,40-dihydroxyphenyl)-g-valerolactone, 5-phenyl-g-valerolactone and phenylpropionic
acid. However, the formation of these metabolites from (þ )-catechin required its initial conversion to (þ )-epicatechin. The metabolism of both
flavanols occurred in the presence of favourable carbon sources, notably sucrose and the prebiotic fructo-oligosaccharides, indicating that bacterial
utilisation of flavanols also occurs when preferential energy sources are available. (þ )-Catechin incubation affected the growth of select micro-
flora, resulting in a statistically significant increase in the growth of the Clostridium coccoides–Eubacterium rectale group, Bifidobacterium spp.
and Escherichia coli, as well as a significant inhibitory effect on the growth of the C. histolyticum group. In contrast, the effect of (2)-epicatechin
was less profound, only significantly increasing the growth of the C. coccoides–Eubacterium rectale group. These potential prebiotic effects for
both (þ )-catechin and (2 )-epicatechin were most notable at the lower concentration of 150mg/l. As both (2)-epicatechin and (þ )-catechin were
converted to the same metabolites, the more dramatic change in the growth of distinct microfloral populations produced by (þ )-catechin incu-
bation may be linked to the bacterial conversion of (þ )-catechin to (þ)-epicatechin. Together these data suggest that the consumption of flava-
nol-rich foods may support gut health through their ability to exert prebiotic actions.
Flavanols: Prebiotics: Faecal microflora: Large intestine
Representing one of the most important lifestyle factors, diet
can strongly influence the incidence and onset of CVD(1),
and thus a healthy diet is an essential factor for healthy
ageing(2). A number of dietary intervention studies in human
subjects and animals, in particular those using Vitis vinifera
(grape), Camellia sinensis (tea) and Theobroma cacao
(cocoa) have demonstrated beneficial effects on vascular func-
tion(3–5). While such foods and beverages differ greatly in
chemical composition and macro- and micronutrient content,
they have in common that they are amongst the major dietary
sources of flavanols. The in vivo effects of flavanols will be
dependent on the absorption and metabolism of flavanols in
the gastrointestinal tract. Studies have indicated that flavanols
are subject to extensive metabolism by phase I and II enzymes
to yield O-methylated, sulfated and glucuronidated forms
during transfer from the small-intestinal lumen to the portal
blood(6). However, significant amounts of ingested (2 )-epica-
techin, (þ)-catechin, and their structurally related oligomeric
forms (procyanidins), escape absorption in the small intestine,
instead reaching the large intestine, where they encounter the
resident colonic microflora(7).
The human large intestine is an extremely active fermentation
site and is inhabited by over 400 different bacterial species which
number about 1014 colony-forming units in total(8). The balance
among these bacterial species has been linked to both beneficial
anddetrimental effects in the large intestine.For example, the pro-
gression of colorectal cancer and inflammatory bowel disease is
associated with deleterious bacterial species, such as certain
members of the Clostridium group, whilst others, such as Bifido-
bacterium and Lactobacillus spp., are known to exert beneficial
effects in the colon(9–12) and have been utilised in the develop-
ment of probiotic functional foods(8,13). In addition, there has
been much recent interest in the development of ‘prebiotics’,
defined as non-digestible food ingredients that have a beneficial
effect on the host by selectively stimulating the growth of a lim-
ited number of specific bacterial strains in the large intestine(14).
For a nutrient to be classified as a prebiotic it has to fulfil three cri-
teria: (a) itmust undergo a low level of hydrolysis or absorption in
the stomach and/or small intestine; (b) itmust be selective for ben-
eficial commensal bacteria in the colon by encouraging the
growth and metabolism of these organisms; (c) it must alter the
microflora to a healthy composition by inducing beneficial
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luminal or systemic effects within the host(15). Presently, themost
widely used prebiotics are fructo-oligosaccharides (FOS) and
galacto-oligosaccharides and studies have indicated the bifido-
genic and anti-cancer potential of these carbohydrates(16–18).
However, whilst soyabean isoflavones have been shown to pos-
sess prebiotic potential in vivo(19), there is limited information
regarding the potential prebiotic potential of other classes of fla-
vonoids, including the flavanols.
Previous in vitro investigations have indicated that flav-
anols, including procyanidins, are catabolised by the colonic
microflora to low-molecular-weight compounds such as pheny-
lacetic, phenylpropionic and phenylvaleric acids, which are
mono-hydroxylated primarily in the meta or para position(20).
Furthermore, (2)-epigallocatechin and (2)-epicatechin have
been shown to be metabolised to 5-(30,40,50-trihydroxyphenyl)-
g-valerolactone and 5-(30,40-dihydroxyphenyl)-g-valerolactone
by the intestinal microflora(21). A recent in vitro study indicated
that the fermentation of the tea polyphenols, catechin, epicate-
chin, 30-O-methyl gallic acid, gallic acid and caffeic acid, by
various pure isolates of pathogenic and commensal intestinal
bacterial species leads to the generation of a variety of aromatic
metabolites. Incubation of these polyphenols with the pure
bacterial isolates significantly inhibited the growth of certain
pathogenic bacterial species compared with other commensal
anaerobes(22). The aim of the present study was to investigate
the potential of the flavanol monomers, (2 )-epicatechin and
(þ)-catechin, to influence the growth of specific bacterial
groups in a pH-controlled, stirred, batch-culture fermentation
system that is reflective of the environmental conditions located
in the distal region of the human large intestine. We detail the
differential metabolism of flavanols in this competitive bacterial
environment and show that they are capable of inducing positive
changes in the balance of bacterial groups.
Materials and methods
Materials
Unless otherwise stated, all chemicals and reagents were
obtained from Sigma-Aldrich Co. Ltd (Poole, Dorset, UK) or
Fisher (Loughborough, Leics, UK). Bacteriological growth
media supplements were obtained from Oxoid Ltd (Basing-
stoke, Hants, UK). (þ)-Catechin (. 99% pure) and (2)-epica-
techin (. 90% pure) were purchased from Sigma-Aldrich.
(þ)-Epicatechin was obtained from Mars, Inc. (Hackettstown,
NJ, USA). Raftilose P95 FOS was purchased from Orafti
(Tienen, Belgium). HPLC columns were purchased from
Waters Co. (Watford, Herts, UK) and Sumika Chemical Anal-
ysis Service (Singapore). Isopore (0·2 mm) membrane filters
were obtained from Millipore Corp. (Watford, Herts, UK).
All the oligonucleotide probes used for fluorescent in situ
hybridisation (FISH) were commercially synthesised and
labelled with the fluorescent dye Cy3 by MWG-Biotech Ltd
(Milton Keynes, Bucks, UK). Sterilisation of media and instru-
ments was achieved by autoclaving at 1218C for 15min.
Faecal sample preparation
Faecal samples were collected from three separate individuals.
All volunteers were in good health and had not ingested
antibiotics for at least 6 months before the study. Samples
were collected, on site, on the day of the experiment
and were used immediately. The samples were diluted 1:10
(w/v) with anaerobic phosphate buffer (0·1 M; pH 7·4) and
homogenised in a stomacher for 2min. Resulting faecal slur-
ries from each individual (i.e. faecal samples were not
pooled) were used to inoculate the batch-culture vessels.
Batch-culture fermentation
Batch-culture fermentation vessels (300ml volume; one vessel
per treatment group) were sterilised and filled with 135ml
basal nutrient medium (peptone water (2 g/l), yeast extract
(2 g/l), NaCl (0·1 g/l), K2HPO4 (0·04 g/l), KH2PO4 (0·04 g/l),
NaHCO3 (2 g/l), MgSO4.7H2O (0·01 g/l), CaCl2.6H2O
(0·01 g/l), Tween 80 (2ml/l), haemin (50mg/l), vitamin K1
(10 ml/l), L-cysteine (0·5 g/l), bile salts (0·5 g/l), resazurin
(1mg/l) and distilled water). The pH of the basal medium
was adjusted to 7·0 and autoclaved before dispensing it to
the vessels. Medium was then gassed overnight with O2-free
N2. Before the addition of faecal slurry samples, the tempera-
ture of the basal nutrient medium was set to 378C by using a
circulating water-bath and the pH was maintained at 6·8, using
an Electrolab pH controller, in order to mimic conditions
located in the distal region of the human large intestine
(anaerobic; 378C; pH about 6·8). Vessels were inoculated
with 15ml faecal slurry (1:10, w/v) and batch cultures were
run under anaerobic conditions for a period of 48 h during
which samples (3ml) were collected at seven time points (0,
4, 8, 10, 17, 24 and 48 h) for FISH, flavanol metabolism anal-
ysis by HPLC and assessment of the total antioxidant capacity
(ferric-reducing antioxidant power (FRAP) assay). Before
FISH analysis, duplicate samples were fixed overnight at
48C with 4% (w/v) paraformaldehyde. The remaining
sample was centrifuged for 5min at 1500 g and the super-
natant fraction was removed and stored in sterile Eppendorf
tubes (1·5ml) at 2208C to be analysed later by HPLC and
in the FRAP assay.
Inoculation of substrate in the batch culture
(þ)-Catechin and (2 )-epicatechin (150mg/l and 1000mg/l)
were inoculated in stirring batch-culture vessels (one per treat-
ment) containing faecal slurry (1:10, w/v). These amounts
were estimated to reflect lower and upper levels of flavanol
monomer intake. We also investigated the metabolism of com-
pounds (1000mg/l) in the presence of sucrose (1%, w/v) and
in the presence of a known prebiotic compound, FOS (1%, w/v).
Control experiments incubating flavanol monomers in medium
without faecal slurry inoculation were also run under anaerobic
conditions.
Bacterial enumeration
In order to access the differences in bacterial population, FISH
was used with oligonucleotide probes designed to target
specific diagnostic regions of 16S rRNA. The probes were
commercially synthesised and labelled with the fluorescent
dye Cy3. The bacterial groups studied for enumeration were
Bifidobacterium spp., Bacteroides spp., Lactobacillus/Entero-
coccus spp., Clostridium coccoides–Eubacterium rectale
group, C. histolyticum group and Escherichia coli using the
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specific probes Bif164, Bac303, Lab158, Erec482, His150 and
Ec1531 respectively. For total bacterial count 4,6-diamidino-
2-phenylindole nucleic acid stain was utilised. Samples fixed
in 4% paraformaldehyde overnight at 48C were then centri-
fuged at 1500 g for 5min, washed twice with PBS (0·1 M;
pH 7·0), re-suspended in a mixture of PBS–99% ethanol
(1:1, v/v) and stored at 2208C for at least 1 h. This process
was used for all samples except those where the Lab158
probe was used. Samples probed with Lab 158 were subjected
to an additional enzyme step (25mM-tri(hydroxymethyl)-ami-
nomethane-HCl, 10mM-EDTA, 585mM-sucrose, 5mM-CaCl2,
sodium taurocholate (0·3mg/ml), lysozyme (2mg/ml), lipase
(0·1mg/ml)) for 60min at 378C in order to increase cell
permeability.
Cell suspensions were then added to the filtered steri-
lised hybridisation mixture (30mM-tri(hydroxymethyl)-amino-
methane-HCl, 1·36 M-NaCl, 0·15% SDS, pH 7·2) and were left
overnight to hybridise at the appropriate temperature for each
probe. Hybridised mixtures were vacuum filtered using 0·2 (m
pore-size isopore membrane filters (Millipore Corporation,
Watford, Herts, UK) and filters were placed onto labelled
glass slides. A drop of Slowfade (Molecular Probes, Eugene,
OR, USA) was added to each and a cover slip was placed
on top of each filter and slides were stored in the dark at
48C. Slides were examined after 60min using a fluorescent
microscope (Nikon Eclipse E400). 4,6-Diamidino-2-phenylin-
dole-stained cells were examined under UV light and a
DM510 light filter was used to count micro-organisms hybri-
dised with the probes. For each slide, fifteen different fields of
view were counted. In order to determine the changes in the
bacterial population we used an ‘index of specific bacteria’
(ISB). The ISB was calculated using the following equation:
ISB ¼ (Ns (T1) – Ns (T0)) – (Nc (T1) – Nc (T0)), where
Ns is the number log10 of specific bacteria in a specific test
sample (i.e. treated with flavanol), Nc is the number log10 of
specific bacteria in the control (no addition of flavanol), T1
is a specific time point and T0 is the 0 h time point. The con-
trol vessel contained only basal medium and faecal slurry
(1:10, w/v) without any addition of flavanols.
High-performance liquid chromatography analysis
Analysis of flavanols and metabolites in the batch-culture
vessels was assessed using a Hewlett-Packard 1100 series
chromatograph (Hewlett-Packard, Palo Alto, CA, USA)
equipped with a diode array detector and linked to the HP
Chemstation Software system. Batch-culture supernatant frac-
tion samples were diluted 1:5 in Milli-Q water before analysis
using a reversed-phase C18 Nova-Pak column (4·6 £ 250mm)
(Waters Co.) with 4 mm particle size. The mobile phase con-
sisted of: (A) aqueous methanol (5%) in 5 M-hydrochloric
acid (0·1%) and (B) acetonitrile–methanol (1:1) and was
pumped through the column at 0·7ml/min. The following gra-
dient system was used, where the percentage of solvent B was
increased at the following times (min/% B): 0/0, 5/5, 40/50,
60/5 for detection of all compounds; the total run time was
60min. The eluant was monitored by photodiode array detec-
tion at 280 nm and spectra of products obtained over the 220–
600 nm range. Calibration curves of catechin and epicatechin
were constructed using authentic standards (0–100mM) and
in each case were found to be linear with correlation coeffi-
cients of . 0·995.
Chromatographic chiral analyses were performed onHP 1100
Series HPLC (Hewlett-Packard) coupled to a fluorescence
detector. Separations were carried out using a 4·6 £ 250mm;
5mmSumichiral OA-7000 column (Sumika Chemical Analysis
Service Ltd, Singapore) with a 10 ml injection volume. The
binary mobile phase consisted of (A) 0·1% acetic acid in
water and (B) 0·1% acetic acid in acetonitrile, with the isocratic
separation carried out using 15% solvent B. The flow rate of
0·250ml/min was used throughout the run, which lasted
100min. Standards and samples were detected using a
fluorescence detector with an excitation wavelength of 276 nm
and emission wavelength of 316 nm. Confirmation of the
structure of (þ)-epicatechin and (2 )-epicatechin was
confirmed by retention time, spectral mapping and by spiking
with authentic standards.
Measurement of antioxidant potential of batch-culture
mixtures
The FRAP assay was used as a direct measurement of the total
antioxidant potential of each sample. The assay was performed
as previously described(23) with minor modifications. Briefly,
sodium acetate trihydrate (300mM), 2,4,6-tripyridyl-s-triazine
(10mM) in HCl (40mM) and FeCl3.6H2O (20mM) were com-
bined in a 10:1:1 ratio to obtain the FRAP reagent. Sample
analysis was preformed on a ninety-six-well plate where
40 ml of appropriately diluted sample were added to 300 ml
FRAP reagent in each well. Samples were analysed in tripli-
cate. Plates were analysed using a GENios pro (Tecan,
Theale, Berks, UK) spectrophotometer linked to the Magellan
software program. The change of absorbance at 593 nm over
4min is proportional to the combined (total antioxidant)
FRAP value of the antioxidants in the sample. Untreated
faecal supernatant fractions from the batch cultures were
used as control and ascorbic acid was used as the positive
control.
Statistical analysis
Each flavanol monomer was tested at two concentrations
(150mg/l or 1000mg/l) in batch cultures inoculated with
faecal samples collected from three individual donors.
Experiments were performed in duplicate (i.e. each donor
donated a faecal sample on two separate occasions). For
bacterial enumeration work, changes in bacterial groups, cal-
culated using the ‘index of specific bacteria’ (see Bacterial
enumeration section), were expressed as mean values and
standard deviations. A paired Student’s t test was used to
test for significant differences at 10 h for flavanols
(150ml/l) and 17 h for flavanols (1000mg/l) between the
control vessel and flavanol-containing vessels. The rationale
for the selection of these time points is discussed in the
Results section. For the antioxidant potential work (FRAP
assay) the results were expressed as mean values and stan-
dard deviations and significance was analysed using paired
Student’s t tests. Significant differences in batch-culture fla-
vanol levels were assessed using an unpaired t test with
Welsh’s correction.
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Results
Metabolism of flavanols by human faecal bacteria
We applied a pH-controlled, stirred, batch-culture fermenta-
tion system inoculated with a faecal slurry (1:10, w/v) to
determine the metabolism of (2)-epicatechin and (þ)-cate-
chin in a competitive microbial environment that mimics the
distal large intestine. Fermentation suspensions were treated
with (2 )-epicatechin or (þ)-catechin, and samples were col-
lected as a function of time and analysed by HPLC for charac-
terisation and quantification of intact flavanols and derived
bacterial metabolites. Fig. 1 shows representative HPLC chro-
matograms and related spectral peak information for the
metabolism of (2)-epicatechin by the microflora. (2 )-Epica-
techin was degraded progressively over a 24 h period but was
not fully degraded in this time frame. Three major metabolites
with similar spectral characteristics were observed at retention
times of 18·4 (A1), 19·8 (A2) and 24·3 (A3) min, suggesting
that they are more polar than epicatechin itself (Fig. 1 (A)).
The metabolite at 18·4min (A1) was identified as 5-(30,40-
dihydroxyphenyl)-g-valerolactone by MS, with analysis indi-
cating that its amount increased as a function of exposure
time (Fig. 1 (B)). Metabolite A2 was characterised by LC–
MS/MS to be phenylpropionic acid (m/z 151; [M þ Hþ]þ)
whilst A3 was determined to be 5-phenyl-g-valerolactone
(m/z 191; [M þ Hþ]þ).
When (þ)-catechin was incubated under the same con-
ditions, the formation of four major, more polar, metabolites
was observed at 11·3 (B2), 19·4 (B1), 24·0 (B3) and 25·6
(B4) min retention times (Fig. 2 (B)) over the course of
24 h. The major metabolite formed at 10 h (B4) was deter-
mined to be either (þ)-epicatechin or (2 )-epicatechin by
comparison with authentic standards and LC–MS/MS analysis
(Fig. 2 (B)). Chiral separation of this sample by HPLC further
identified this peak as (þ)-epicatechin (Fig. 3). Metabolite B1,
which also appeared after 10 h of incubation, eluted at a simi-
lar retention time to A1 and had similar spectral character-
istics. Mass spectral analysis of B1 confirmed that this
metabolite was also 5-(30,40-dihydroxyphenyl)-g-valerolactone
(molecular weight of 207 detected in negative ion mode) and
B3 was 5-phenyl-g-valerolactone (m/z 191; [M þ Hþ]þ). The
rate of (þ)-catechin metabolism by the microflora was signifi-
cantly greater than that observed for (2)-epicatechin, with
levels of (þ)-catechin significantly lower at 4 h (P,0·01)
and 8 h (P,0·001) at the 150mg/l exposure (Fig. 4(A)) and
at 8 h (P,0·01), 10 h and 17 h (P,0·001) at the 1000mg/l
exposure (Fig. 4 (B)). This appeared to be due in part to the
conversion of (þ)-catechin to (þ)-epicatechin during catechin
fermentation experiments (Fig. 3). Degradation of both flava-
nols was influenced by individual variation in the composition
of the faecal microflora, yielding relatively large inter-individ-
ual variation (Fig. 4). However, although the time course for
different donors varied slightly, all donors yielded the same
metabolites for (2)-epicatechin and (þ)-catechin. No epimer-
isation of (2 )-epicatechin or (þ)-catechin was observed when
flavanols were added to batch-culture systems without faecal
inoculum (data not shown). In control experiments, no degra-
dation of either (þ)-catechin or (2 )-epicatechin was observed
when flavanols (1000mg/l) were incubated in anaerobic batch-
culture vessels for 24 h without faecal inoculation.
Microflora-induced metabolism of both (2 )-epicatechin
and (þ)-catechin was also observed in the presence of the
favourable bacterial carbon sources, sucrose and the known
prebiotic, FOS (Fig. 5), indicating bacterial metabolism of fla-
vanols occurs even in the presence of preferential energy
sources. Previous investigations have indicated that flavonoids
may be metabolised by the gut microflora, although this is the
first time their metabolism has been observed in the presence
of alternate energy sources, a model which is more reflective
of in vivo conditions. The extent of (2)-epicatechin metab-
olism by bacteria was significantly greater at both 8 h and
10 h (P,0·01) in the presence of both sucrose and FOS,
with the combination of (2 )-epicatechin þ1% FOS resulting
in the greatest reduction in flavanol relative to (2 )-epicatechin
alone (Fig. 5 (A)). This was also apparent with (þ)-catechin
metabolism, with both sucrose and FOS significantly increas-
ing the extent of bacterial (þ)-catechin metabolism at 4 h
(P,0·01), 8 h and 10 h (P,0·001) (Fig. 5 (B)). There were
no significant differences between the flavanol þ sucrose
treatments and flavanol þ FOS treatments (P.0·05).
Changes in antioxidant potential
The metabolism of both flavanols over the 24 h batch-culture
incubation period was paralleled by decreases in the total anti-
oxidant capacity of the batch-culture mixtures. Batch cultures
containing (2 )-epicatechin (150mg/l) showed a time-depen-
dent reduction in antioxidant capacity, which achieved signifi-
cance at 17 and 24 h of incubation with the microflora.
Similarly, there was a decrease in antioxidant activity in
batch cultures exposed to (þ)-catechin (Fig. 6). However,
vessels treated with either (þ)-catechin or (2 )-epicatechin
had increased antioxidant activity compared with untreated
vessels at all time points with the exception of 24 h (Fig. 6).
Flavanol-induced changes in specific bacterial groups
In order to assess the changes in bacterial populations in
response to (2 )-epicatechin or (þ)-catechin exposure, we uti-
lised FISH analysis. Previous in vitro and in vivo studies
designed to assess potential prebiotic effects of different sub-
strates have successfully utilised FISH analysis to enumerate
different bacterial groups found in the human faecal micro-
flora and their changes over time(24,25). FISH analysis was per-
formed at time points where more than 50% of flavanol had
been metabolised by the faecal microflora in the mixed
batch culture. This was revealed by HPLC analysis to be
10 h for experiments with (þ)-catechin and (2 )-epicatechin
at 150mg/l and 17 h at 1000mg/l (Fig. 4). (2)-Epicatechin
(150mg/l) caused a significant increase in the growth of the
beneficial bacterial group, Eubacterium rectale–C. coccoides
(Fig. 7 (A)), as revealed by an increase in the number of
this bacterial group in vessels containing (2)-epicatechin,
compared with the number found in control vessels, at the
same time point (index of specific bacteria). However, (2 )-
epicatechin did not induce any other significant changes in
the microflora either at the 150 or 1000mg/l concentration.
The significant increase in Eubacterium rectale–C. coccoides
was only observed at the lower concentration of (2 )-epicate-
chin (Fig. 7 (A)). There was no significant difference between
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Fig. 1. Bacterial-dependent metabolism of (2 )-epicatechin (EC). (A) Typical HPLC chromatogram with photodiode array spectra (200–600 nm) of faecal super-
natant fraction derived from the batch culture with EC at 1000 mg/l concentration after 0, 8 and 24 h of incubation with human colonic bacteria. EC and three new
compounds (A1–A3) were detected. (B) LC-MS/MS analysis of peak A1 confirming the presence of 5-(30,40-dihydroxyphenyl)-g-valerolactone [n-Hþ]þm/z 207.
Inset panel shows the relative signal for [n-Hþ]þm/z 207 in 0, 8 and 24 h batch-culture samples. cps, Counts per s; amu, atomic mass units.
X. Tzounis et al.786
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
Fig. 2. Bacterial-dependent metabolism of (þ)-catechin. (A) Typical HPLC chromatogram with photodiode array spectra (200–600 nm) of faecal supernatant fraction
derived from the batch culture with (þ )-catechin at 1000 mg/l concentration after 0, 8 and 24 h of incubation with human colonic bacteria. (þ )-Catechin (C) and four
new compounds (B1–B4) were detected. (B) LC-MS/MS analysis of the same sample indicating the presence of a compound with m/z 291 at two retention times.
(i) Selected ion scan of [n-Hþ]þm/z 291; (ii) selected ion scan [n-Hþ]þm/z 291 overlaid with [n-Hþ]þm/z 139 (B); (iii) fragment ion spectrum of epicatechin showing
the abundant signal at m/z 139 representing the retro Diels–Alder product deriving from the A-ring. cps, Counts per s; RT, retention time; amu, atomic mass units.
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the low flavanol (150mg/l) treatment and the high flavanol
(1000mg/l) treatment (P.0·05).
In contrast, (þ)-catechin exposure resulted in a greater modi-
fication in the growth of the bacterial groups compared with that
seen with (2 )-epicatechin (Fig. 7 (B)). There was a significant
decrease in the growth of the C. histolyticum group at the
1000mg/l concentration, relative to control, and a marked
increase in the growth of the beneficial bacterial group ofC. coc-
coides–Eubacterium rectale at both the 150mg/l and 1000mg/l
exposure concentrations. Furthermore, there were increases in
both Lactobacillus spp. and Bifidobacterium spp. following
(þ)-catechin (150mg/l exposure), which achieved significance
for the latter. There were also small, but significant increases, in
the growth of E. coli in response to catechin (150mg/l) incu-
bationwith the bacterial culture. There was no significant differ-
ence in the total number of microbes measured in vessels
containing either flavanol (150 or 1000mg/l), compared with
the total number measured in the control vessels.
Discussion
In recent years there has been much interest in the develop-
ment of nutritional products that are based on a prebiotic prin-
ciple. Prebiotics are non-digestible food ingredients that
beneficially affect the host by selectively stimulating the
growth and/or activity of one, or a limited number of, ben-
eficial bacteria in the colon(8). Although the effects of many
carbohydrates have been investigated as potential prebiotics,
for example inulin and FOS, few studies have considered
the prebiotic potential of other dietary components. Flavo-
noids are potential prebiotic candidates as they are known to
undergo limited absorption and metabolism in the upper gas-
trointestinal tract (stomach, duodenum and jejunum), with
the majority reaching the large intestine intact(26) where
approximately 200 g of material (water, bacteria, food par-
ticles and mucus) are present at any given time(27). Green
tea contains up to 8·5mg (2 )-epicatechin/100ml and 2·8mg
Fig. 3. Chiral separation of peak B4 derived from the batch culture with (þ )-catechin following 10 h fermentation. Indication that metabolite B4 (see Fig. 2) relates
to (þ )-epicatechin. Detection was by fluorescence (excitation 276 nm and emission 316 nm). The sample containing peak B4 (A) was spiked with authentic (2 )-
epicatechin (B) or (þ )-epicatechin (C). (D) (þ)-Epicatechin standard; (E) (2 )-epicatechin standard. LU, luminosity units.
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(þ)-catechin/100ml(28), 100 g dark chocolate contains, on
average, 42mg (2 )-epicatechin and 12mg (þ)-catechin. In
the present study we show that the metabolism of the flavanol
monomers, (2)-epicatechin and (þ)-catechin, by a human
bacterial population representative of the distal part of the
human large intestine leads to changes in the growth of
specific bacterial populations. Specifically, (þ)-catechin, and
to a lesser extent (2)-epicatechin, had a positive effect on
the growth of C. coccoides–Eubacterium rectale, a bacterial
group which has been associated with beneficial effects at
the cellular and systemic level due to their ability to generate
SCFA by saccharolytic metabolism(29). The flavanol-induced
increases in this bacterial group seen in our investigations
may result in an increased potential for saccharolytic
metabolism in the large intestine, an event believed to be ben-
eficial primarily due to the production of the SCFA acetate,
propionate and butyrate. The generation of such SCFA in
the large intestine is considered positive for gut health as
they have been linked to an inhibition of pre-neoplastic pro-
liferation and an acceleration of the conversion of cholesterol
into bile acids(30).
(þ)-Catechin exposure also resulted in the small, but sig-
nificant, increase in the growth of bifidobacteria, a group
which has been strongly associated with positive effects in
the large intestine(8), through their ability to inhibit the
Fig. 4. Metabolism profiles of (þ)-catechin (X) and (2 )-epicatechin (B) from
three individual donors performed in duplicate. (A) Flavanol (150 mg/l); (B)
flavanol (1000 mg/l). Results are expressed as amount (g/l) in batch-culture
medium. Values are means (n 6), with standard deviations represented by
vertical bars. Significant difference between (þ)-catechin and (2 )-epicate-
chin concentrations in batch-culture vessels: **P,0·01, ***P,0·001.
Fig. 5. Flavanol metabolism in the presence of carbohydrates. (2 )-Epicate-
chin (A) and (þ)-catechin (B) assimilation profiles in pH-controlled batch cul-
tures in the presence of 1 % fructo-oligosacchrides (FOS) or 1 % sucrose.
(A): (B), (2 )-Epicatechin; (X), (2 )-epicatechin þ1 % sucrose; (O), (2 )-epi-
catechin þ1 % FOS. (B): (B), (þ )-Catechin; (X), (þ )-catechin þ1 % sucrose;
(O), (þ )-catechin þ1 % FOS. Results are expressed as concentration (g/l) in
batch-culture medium. Values are means (n 6), with standard deviations
represented by vertical bars. Mean values of flavanol only and flavanol þ
FOS/sucrose were significantly different: **P,0·01, ***P,0·001.
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growth of pathogenic micro-organisms. (þ)-Catechin-induced
changes in bifidobacteria may stimulate the generation of
organic acids, such as acetic and lactic acid in the colon(21)
and may inhibit the ability of potential pathogenic species to
colonise the gut epithelial lair(15). Furthermore, (þ)-cate-
chin-induced decreases in the C. histolyticum group, a group
of mostly proteolytic bacteria, may be particularly relevant
in the distal large intestine where proteolytic metabolism has
been proposed to contribute to the progression of colonic
cancer and the onset of inflammatory bowel disease(31). Bac-
terial groups, such as Bacteroides and Clostridium favour pro-
teolytic fermentation, which results in the production of
ammonia, thiols, amines and indoles, endproducts that have
been connected with neoplastic growth and cancer(32,33). It is
more difficult to interpret the small E. coli increases observed
in response to (þ)-catechin exposure, as the probe used in our
investigations enumerates both commensal and pathogenic
strains of E. coli. Further investigation is required to identify
the specific strains affected in our system. However E. coli is
one of the most common bacteria inhabiting the intestinal tract
of humans, and thus the observed increase is unlikely to rep-
resent a change in the small number of strains responsible for
diarrhoeal diseases(34).
The significant changes in bacterial composition in response
to (þ)-catechin were accompanied by its rapid conversion to
(þ)-epicatechin. Recently, Lee et al. reported similar conver-
sions of catechin to epicatechin upon bacterial incubation,
although in their study they did not confirm the specific isomeric
form as was done in the present investigation(22). In contrast to
the present study, we only observed the conversion of (þ)-cate-
chin to (þ)-epicatechin in the presence of bacteria, suggesting
that it is the microflora that mediate this conversion. Moreover,
our data indicate that the reduction in flavanol monomer
concentration in batch-culture vessels is entirely due to specific
bacterial-dependent metabolism, rather than unspecific bac-
terial-independent degradation, as we did not observe degra-
dation of either flavanol, for example by their oxidation, in our
anaerobic batch-culture environment. As there were no major
differences in the other metabolites produced from either (þ)-
catechin and (2)-epicatechin, with both yielding 5-(30,40-dihy-
droxyphenyl)-g-valerolactone, 5-phenyl-g-valerolactone and
phenylpropionic acid following incubation with the microflora,
the greater influence of (þ)-catechin on the growth of specific
microflora may be the result of the bacterial-driven formation
of (þ)-epicatechin from (þ)-catechin.
The formation of valerolactone species from flavanols in the
large intestine has previously been reported(20,21,35,36) and
such metabolic products may represent potential bioactive
metabolites of flavanols in vivo following their absorption into
the circulation via the gut wall. This generation of metabolites
Fig. 6. The effect of bacterial metabolism on antioxidant potential. Changes
in the antioxidant potential of batch-culture mixtures over time following incu-
bation with basal medium only (A), (2 )-epicatechin (150 mg/l) (B) and cate-
chin (150 mg/l) ( ) were determined by the ferric-reducing antioxidant power
assay. The antioxidant activity is expressed as ascorbic acid equivalents
(mmol/l). Values are means (n 6), with standard deviations represented by
vertical bars. Mean antioxidant capacity was significantly decreased com-
pared with that at time 0: *P,0·05, **P,0·01.
Fig. 7. Influence of flavanol monomers on the colonic microflora. Changes in
the bacterial populations during the fermentation of (2 )-epicatechin (A) and
(þ)-catechin (B) in a pH-controlled faecal batch culture. Samples were taken
at 10 and 17 h for 150 mg/l (A) and 1000 mg/l (B) concentrations, respect-
ively and analysed by fluorescent in situ hybridisation. Bif, Bifidobacterium
spp.; Bac, Bacteroides spp.; Lac, Lactobacillus/Enterococcus spp.; Clos,
Clostridium histolyticum group; E. coli, Escherichia coli; Eubac, C. coc-
coides–Eubacterium rectale group. Bacterial changes, calculated using the
‘index of specific bacteria’, are expressed as log10 cells/ml. Changes in bac-
terial growth were calculated by comparing the number of a specific bacterial
group in the treatment group with the number found in a control group, at the
same time point. Values are means (n 6), with standard deviations rep-
resented by vertical bars. Mean value was significantly different from that of
the control: *P,0·05, ***P,0·001.
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was also marked by a general reduction in the antioxidant poten-
tial of the batch-culture mixture, suggesting that species such as
valerolactones possess lower antioxidant potential compared
with native flavanols. However, despite this significant
reduction in antioxidant activity, regular flavanol-rich food con-
sumption is likely to result in a general increase in the antioxi-
dant capacity in the large intestine. This may be relevant in
reducing oxidative stress in the large intestine that occurs as a
result of inflammatory events experienced during inflammatory
bowel disease(37). Previous studies have shown that dietary-
derived antioxidants may exert a beneficial effect on large-intes-
tinal disorders, such as inflammatory bowel diseases, where they
act to reduce the levels of certain cytokines and scavenge
oxidation products derived from other dietary factors or from
bacterial oxidative metabolism(38,39).
The generation of metabolic products following incubation
with the bacteria suggests that flavanols may be potential
nutrient sources for the bacteria. Indeed, both flavanols were
metabolised by the human colonic bacteria even in the pre-
sence of carbohydrate energy sources, notably sucrose and
the pre-biotic FOS, suggesting that the metabolism of
flavanols may occur even in the presence of more favourable
carbon sources. These observations suggest that these flavanol
monomers may be capable of influencing the large-intestinal
bacterial population even in the presence of other nutrients,
such as carbohydrates and proteins. Our data indicate that fla-
vanols have an ability to influence the growth of specific
large-intestinal bacteria and that this ability may be linked
to specific metabolic transformations, such as the bacterial
conversion of (þ)-catechin to (þ)-epicatechin. However, we
acknowledge that this is an in vitro investigation using a
batch-culture model and it may not necessarily explain with
certainty the effects of flavanols in humans. Future human
intervention studies will provide further insight into the poten-
tial of flavanol monomers to act as prebiotics in the human
large intestine in vivo.
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